Carloni, Paolo
 Distribuzione geografica
Continente #
NA - Nord America 1.059
EU - Europa 949
AS - Asia 327
Continente sconosciuto - Info sul continente non disponibili 7
AF - Africa 1
Totale 2.343
Nazione #
US - Stati Uniti d'America 1.029
IE - Irlanda 210
SE - Svezia 202
CN - Cina 193
IT - Italia 138
RU - Federazione Russa 108
UA - Ucraina 98
TR - Turchia 62
GB - Regno Unito 53
DE - Germania 47
HK - Hong Kong 45
CA - Canada 30
FI - Finlandia 21
BE - Belgio 17
FR - Francia 17
GR - Grecia 8
CH - Svizzera 7
EU - Europa 7
VN - Vietnam 7
LB - Libano 5
NL - Olanda 5
PL - Polonia 4
RO - Romania 4
UZ - Uzbekistan 4
AT - Austria 3
CZ - Repubblica Ceca 3
IN - India 3
ES - Italia 2
JP - Giappone 2
MN - Mongolia 2
BD - Bangladesh 1
HR - Croazia 1
KE - Kenya 1
LU - Lussemburgo 1
MY - Malesia 1
PH - Filippine 1
SA - Arabia Saudita 1
Totale 2.343
Città #
Chandler 231
Dublin 210
Ann Arbor 154
Jacksonville 125
Scuola 71
Izmir 62
Nanjing 56
New York 55
Saint Petersburg 53
Ashburn 50
Hong Kong 45
Wilmington 44
Woodbridge 44
Dearborn 39
Toronto 30
Beijing 24
Princeton 21
Ogden 18
Brussels 17
Brooklyn 16
Pisa 16
Kunming 13
Nanchang 12
Hebei 11
Milan 11
Houston 10
Shenyang 9
Tianjin 9
Helsinki 8
Washington 8
Dong Ket 7
Hangzhou 6
Seattle 6
Boardman 5
Falls Church 5
Frankfurt Am Main 5
Leiden 4
Ningbo 4
Orange 4
Trieste 4
Zhengzhou 4
Auburn Hills 3
Bologna 3
Jinan 3
Lausanne 3
Los Angeles 3
Palermo 3
Rietberg 3
Shanghai 3
Thessaloniki 3
Timisoara 3
Bari 2
Candelo 2
Dongguan 2
Duncan 2
Florence 2
Fribourg 2
Genova 2
Hefei 2
Jiaxing 2
Krakow 2
Lanzhou 2
Las Vegas 2
Pontedera 2
Pozuelo del Rey 2
Redwood City 2
Rome 2
Aachen 1
Athens 1
Changchun 1
Changsha 1
Council Bluffs 1
Des Moines 1
Dhaka 1
Fairfield 1
Fuzhou 1
Genoa 1
Guangzhou 1
Hanover 1
Hyderabad 1
Indiana 1
Jülich 1
Landsberg 1
Luxembourg 1
Manila 1
Mumbai 1
Mönchengladbach 1
Nairobi 1
Naples 1
North Bergen 1
Norwalk 1
Redmond 1
Rende 1
San Jose 1
Santa Maria Capua Vetere 1
Sauris 1
Spinea 1
Strasbourg 1
Taizhou 1
Taramani 1
Totale 1.621
Nome #
Serpin inhibitors for the treatment of prion and prion-like diseases 151
Mesencephalic dopaminergic neurons express a repertoire of olfactory receptors and respond to odorant-like molecules 138
Permeability Coefficients of Lipophilic Compounds Estimated by Computer Simulations 133
Unifying view of mechanical and functional hotspots across class A GPCRs 130
Ionic charge transfer effects in water, channels and enzymes 128
Classical and quantum chemical studies of copper phenanthroline complexes binding the DNA 128
Parameterization of novel anticancer drugs via a QM/MM force matching procedure and effect of drug-binding on DNA flexibility 123
Anthrax Lethal Factor Investigated by Molecular Simulations 120
Role of protein frame and solvent for the redox properties of azurin from Pseudomonas aeruginosa 117
Understanding anticancer Drug-DNA interactions via molecular dynamics simulations 116
The hydrolysis mechanism of the anticancer ruthenium drugs NAMI-A and ICR investigated by DFT-PCM calculations 114
Second step of hydrolytic dehalogenation in haloalkane dehalogenase investigated by QM/MM methods 113
Computational Study of the DNA-Binding Protein Helicobacter pylori NikR: The Role of Ni2+ 112
Huntingtin: Stability and Interaction with Molecular Partner from Computational Biophysics Studies 110
Huntigton disease: Cooperative hydrogen bonding in polyQ aggregates 109
Nitrogen fixation by a biologically-inspired catalyst: An ab initio and hybrid qm/mm molecular dynamics study 107
Structural facets of disease-linked human prion protein mutants: A molecular dynamic study 106
Protonation state and substrate binding to B2 metallo-beta-lactamase CphA from Aeromonas hydrofila 104
Dominant-negative effects in prion diseases: insights from molecular dynamics simulations on mouse prion protein chimeras 100
Water and potassium dynamics inside the KcsA K+ channel 90
Common structural traits across pathogenic mutants of the human prion protein and their implications for familial prion diseases 85
Erratum: Common structural traits across pathogenic mutants of the human prion protein and their implications for familial prion diseases 16
Innovative Non-PrP-Targeted Drug Strategy Designed to Enhance Prion Clearance 16
Erratum: Discovery of a class of diketopiperazines as antiprion compounds 14
Totale 2.480
Categoria #
all - tutte 9.150
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.150


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019150 0 0 0 0 0 0 0 0 0 0 21 129
2019/2020413 50 34 69 14 29 31 72 30 23 32 25 4
2020/2021242 32 3 1 27 4 47 25 2 26 27 16 32
2021/2022264 32 24 1 45 35 6 17 18 7 11 24 44
2022/2023573 72 80 54 66 17 121 63 21 58 4 8 9
2023/2024410 15 3 18 9 60 203 22 13 53 13 1 0
Totale 2.480